BlackRock Institutional Trust’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRI
PIP
BFA
VNIM
OWP
ACM
RA
RHJA
EWM
BlackRock Institutional Trust's AMRI Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Albany Molecular Research Inc (AMRI) stake by 0.25% in Q4 2016, buying an estimated $31.1K and bringing the position to 740,681 shares worth $13.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2212.
BlackRock Institutional Trust first reported a position in AMRI in Q2 2013 and has held it in 15 quarters since. The position peaked at $16.3M in Q3 2014. 133 funds tracked by Wall St. Rank hold AMRI as of Q4 2016.
- BlackRock Institutional Trust held 740,681 shares of Albany Molecular Research Inc worth $13.9M as of Q4 2016.
- BlackRock Institutional Trust bought 1,828 Albany Molecular Research Inc shares in Q4 2016, an estimated $31.1K.
- Albany Molecular Research Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2212 holding.
- BlackRock Institutional Trust first reported a position in Albany Molecular Research Inc in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Albany Molecular Research Inc position peaked at $16.3M in Q3 2014.
- 133 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.